For Escherichia coli, growth on acetate requires the induction of the enzymes of the glyoxylate bypass, isocitrate lyase and malate synthase. The branch point between the glyoxylate bypass and the Krebs cycle is controlled by phosphorylation of isocitrate dehydrogenase (IDH), inhibiting that enzyme's activity and thus forcing isocitrate through the bypass. This phosphorylation cycle is catalyzed by a bifunctional enzyme, IDH kinase/phosphatase, which is encoded by aceK. We have employed random mutagenesis to isolate novel alleles of aceK. These alleles were detected by the loss of ability to complement an aceK null mutation. When Escherichia coli grows on acetate, the net synthesis of carbon-containing compounds requires the glyoxylate bypass, a metabolic pathway catalyzed by the enzymes isocitrate lyase and malate synthase (Fig. 1) . The bypass is essential for growth on acetate, since it prevents the loss of the acetate carbons as CO2 in the Krebs cycle (14, 15). The partitioning of isocitrate between the Krebs cycle and the glyoxylate bypass is regulated, in part, by the phosphorylation of isocitrate dehydrogenase (IDH), the Krebs cycle enzyme that competes with isocitrate lyase (2, 9, 11). During growth on acetate, the cell maintains about 70% of the IDH in the inactive, phosphorylated form, reducing its activity and forcing isocitrate through the glyoxylate bypass (18, 20, 21, 25) . The phosphorylation and dephosphorylation of IDH are catalyzed by a bifunctional protein, IDH kinase/phosphatase, the product of aceK (16, 17) . In many strains of E. coli, IDH phosphorylation is required for growth on acetate, since null mutations in aceK prevent growth in this medium (20) .
For Escherichia coli, growth on acetate requires the induction of the enzymes of the glyoxylate bypass, isocitrate lyase and malate synthase. The branch point between the glyoxylate bypass and the Krebs cycle is controlled by phosphorylation of isocitrate dehydrogenase (IDH), inhibiting that enzyme's activity and thus forcing isocitrate through the bypass. This phosphorylation cycle is catalyzed by a bifunctional enzyme, IDH kinase/phosphatase, which is encoded by aceK. We have employed random mutagenesis to isolate novel alleles of aceK. These alleles were detected by the loss of ability to complement an aceK null mutation. The products of one class of these alleles retain IDH kinase activity but have suffered reductions in IDH phosphatase activity by factors9of 200 to 400. Selective loss of the phosphatase activity also appears to have occurred in vivo, since cells exbrtsing these alleles exhibit phenotypes which are reminiscent of strains lacking IDH; these strains are auxotrophic for glutamate. Assays of cell-free extracts confirmed that this phenotype resulted from nearly quantitative phosphorylation of IDIH. The availability of these novel alleles of aceK allowed us to assess the significance %f the precise control which is a characteristic of the IDH phosphorylation cycle in vivo. The fractiomd phosphorylation of IDH was varied by controlled expression of one of the mutant alleles, aceK3, in a wild-type strain. Reduction of IDH activity to 50% of the wild-type level did not adversely affect growth on acetate; However, further reductions inhibited growth, and growth arrest occurred when the IDH activity fell to 15% of the wild-type level. Thus, although wild-type cells maintain a precise effective IDH activity during growth on acetate, this precision is not critical.
When Escherichia coli grows on acetate, the net synthesis of carbon-containing compounds requires the glyoxylate bypass, a metabolic pathway catalyzed by the enzymes isocitrate lyase and malate synthase (Fig. 1) . The bypass is essential for growth on acetate, since it prevents the loss of the acetate carbons as CO2 in the Krebs cycle (14, 15) . The partitioning of isocitrate between the Krebs cycle and the glyoxylate bypass is regulated, in part, by the phosphorylation of isocitrate dehydrogenase (IDH), the Krebs cycle enzyme that competes with isocitrate lyase (2, 9, 11) . During growth on acetate, the cell maintains about 70% of the IDH in the inactive, phosphorylated form, reducing its activity and forcing isocitrate through the glyoxylate bypass (18, 20, 21, 25) . The phosphorylation and dephosphorylation of IDH are catalyzed by a bifunctional protein, IDH kinase/phosphatase, the product of aceK (16, 17) . In many strains of E. coli, IDH phosphorylation is required for growth on acetate, since null mutations in aceK prevent growth in this medium (20) .
In this paper, we report initial efforts directed toward studying IDH kinase/phosphatase by random mutagenesis of aceK. Mutant alleles of aceK were identified by screening for plasmid-borne clones which have lost the ability to complement a null mutation in this gene. Two of these alleles, designated aceK3 and aceK4, encode proteins that retain kinase activity yet have suffered striking reductions in IDH phosphatase activity. These alleles have allowed us to determine the degree to which the ability to grow on acetate is sensitive to the precise fractional phosphorylation of IDH. (24) and contained 200 ,g of ampicillin per ml, 0.2 mM histidine, and either 1% glucose or 2% sodium acetate. L broth contained 1% Bacto-tryptone, 1% NaCl, 0.5% yeast extract, and 200 ,ug of ampicillin per ml.
Bacterial strains. E. coli strains are listed in Table 1 . DL18 is isogenic with DL16 except tlat it is aceK+. DL18 was constructed by cotransduction of the TnJO and recA56 from strain JC10289 into DEK2010 with P1 bacteriophage. Tetracycline-resistant transductants were scored for recA by testing for sensitivity to UV light.
Recombinant DNA procedures. Except where noted, plasmids were manipulated by standard procedures (1, 23).
Isolation of mutant alleles of aceK. Plasmid pDL7, which expresses aceK+ from the tac promoter, was transformed into E. coli strain W3550 (mutD5). Transformants were grown to mid-log phase at 37°C on L broth containing 200 ,ug of ampicillin per ml. Chloramphenicol was then added to 125 ,ug/ml, and incubation continued overnight. Plasmid DNA was isolated by the alkaline sodium dodecyl sulfate procedure.
The parental plasmid used for mutagenesis, pDL7, was capable of restoring strain DEK2011 (aceK) to growth on acetate (16 Plasmid pDL7 and its immediate derivatives, pHL1 and pHL2, were maintained at relatively low copy numbers because each plasmid carries two origins of replication (16) . To increase the copy number of each plasmid, a HindIII fragment containing one of these origins was deleted. These AHindIII derivatives of pDL7, pHL1, and pHL2 are designated pDL9 (aceK+), pDL25 (aceK3), and pDL30 (aceK4), respectively.
All the plasmids used in this study express aceK from the tac promoter, providing the potential for the control of their expression with the gratuitous inducer IPTG. However, repression of these clones by wild-type cells is ineffective, since the number of plasmid copies exceeds the normal cellular level of the lac repressor protein. To ensure efficient regulation of expression, the gene which overproduces the lac repressor, laclIq, was inserted into plasmids expressing aceK+ or aceK3. Plasmid pMC7, which carries lacIq (5), was cleaved with BamHI and then ligated with BamHI-cleaved pDL9 or pDL25. The ligation mixture was used to transform E. coli MM294A to ampicillin resistance. Transformants harboring lacIq on multicopy plasmids were identified as white colonies on minimal glucose plates containing 40 pug of X-Gal (5-bromo-4-chloro-3-indolyl-3-D-galactoside) per ml. (Unfused pMC7 would not be recovered because it does not code for ampicillin resistance.) The identities of the isolated plasmids were confirmed by restriction mapping. These procedures yielded plasmids pDL20 (aceK+) and pDL26 (aceK3).
Determination of enzyme activities. The activity of IDH kinase was determined by monitoring the inhibition of IDH activity which results from the phosphorylation of that protein, as described previously (17) . The reaction mixture contained 25 mM MOPS (pH 7.5), 1 ,uM IDH, 1 mM ATP, 5 mM MgCl2, 100 mM NaCl, 2 mM dithiothreitol, 0. threitol, 0.5 mM EDTA, and 2 mg of bovine serum albumin per ml. The reaction mixtures were incubated at 37°C. One unit of IDH phosphatase yields 50% dephosphorylation of phospho-IDH in 1 min under these assay conditions. IDH activity was measured by monitoring the reduction of NADP at 340 nm. The reaction mixture contained 25 mM MOPS (pH 7.5), 500 p.M Na3DL-isocitrate, 250 ,uM NADP, and 5 mM MgCl2, and the reaction was performed at 37°C.
Protein concentrations were determined by the method of Lowry et al. (22) with bovine serum albumin as the standard.
Determination of the fractional phosphorylation of IDH. The fractional phosphorylation of IDH was determined by assaying cell-free extracts for IDH activity before and after dephosphorylation with IDH phosphatase (20) . Samples (9 ml) were withdrawn from the cultures, mixed with 1 ml of 20-mg/ml bovine serum albumin and immediately disrupted by sonication. Samples were incubated at 37°C in a solution containing 25 mM MOPS (pH 7.5), 100 mM NaCl, 5 mM MgCl2, 1 mM dithiothreitol, 2.5 mM 3-phosphoglycerate, and 25 mM pyruvate in the presence or absence of 1 mM DL-isocitrate-1 mM ADP and 5 to 10 ,ug of purified IDH kinase/phosphatase. The mixtures were assayed periodically to ensure that the dephosphorylation reaction had gone to completion. Since phosphorylated IDH retains less than 0.1% of its original activity, the fraction of dephosphorylated IDH in a sample could be directly calculated from measurements of IDH activity before and after dephosphorylation.
Growth in glucose medium. Starter cultures, grown on MOPS-glucose supplemented with 3 mM glutamate, were harvested by centrifugation, and the pellet was washed with fresh MOPS-glucose medium without glutamate. After the cells were resuspended to an A650 of ca. 0.15, the cultures were incubated with and without glutamate in a gyratory shaker at 37°C. Except where indicated, samples were withdrawn from cultures grown to an A650 of 0.4 and enzyme activities were determined as described above.
Induction of aceK3 or aceK+ on acetate medium. Starter cultures of strain DL18 harboring either plasmid pDL20 (aceK+) or pDL26 (aceK3) were grown in MOPS-acetate medium and were used to inoculate duplicate cultures of fresh acetate medium to an A650 of 0.04. The cultures were incubated in a gyratory shaker at 37°C for two generations (ca. 6 h), and IPTG was then added to one of these cultures to induce expression of the aceK clone. At the indicated times, samples were harvested by centrifugation for assay of IDH kinase and IDH phosphatase activities and for determination of the fractional phosphorylation of IDH, as described above.
RESULTS
Isolation of mutants alleles of aceK. Random mutagenesis of aceK, the gene encoding IDH kinase/phosphatase, was employed to examine the structure and regulation of that protein. A clone of aceK was mutagenized by replicating plasmid pDL7 in the E. coli mutator strain W3550 (mutD5). Potential mutant alleles were identified by loss of the ability to restore strain DEK2011 (aceK) to growth on acetate. Cell-free extracts were then assayed for the presence of IDH kinase and IDH phosphatase activity. The products of two mutant alleles, aceK3 and aceK4, had suffered striking reductions in IDH phosphatase activity yet retained essentially wild-type levels of IDH kinase activity (Table 2) . Sequence analysis has demonstrated that aceK3 and aceK4 are distinct alleles which have each suffered a single point mutation (12a) .
The products of aceK3 and aceK4 are deficient in IDH phosphatase activity in vivo. If the in vivo properties of the products of aceK3 and aceK4 parallel the properties observed in vitro, IDH should then be more extensively phosphorylated in cells expressing these alleles than in cells expressing aceK+. Since phospho-IDH is inactive, extensive phosphorylation of IDH could, in extreme cases, yield a phenotype equivalent to that exhibited by mutants lacking IDH: an auxotrophic requirement for glutamate (10) . Consistent with this prediction, cells expressing aceK3 maintained less than 1% of their IDH in the active form and exhibited an absolute requirement for glutamate (Table 2) . In contrast, a congenic wild-type strain, whose growth was unaffected by glutamate, maintained 60% of its IDH in the dephosphorylated form. The phenotype of cells expressing aceK4 was similar to that resulting from expression of aceK3; only 3% of the IDH was maintained in the dephosphorylated form, and glutamate was required for optimal growth, although growth occurred in its absence. These observations indicate that the products of aceK3 and aceK4 had suffered drastic reductions in IDH phosphatase activity in vivo as well as in vitro.
Although cells expressing aceK3 or aceK4 were capable of growth when glutamate was provided, their growth rate was substantially less than that observed for a congenic wild-type strain. This phenotype is reminiscent of that produced by mutations in icd, the structural gene for IDH (10) . We have made similar observations for an icd strain which is congenic with DL16 (not shown). Thus, the phenotypes produced by aceK3 and aceK4 closely parallel those of an icd mutant. The significance of this observation is discussed below. Interestingly, the cultures that expressed aceK3 and aceK4 maintained substantially higher total levels of IDH (phospho-IDH plus dephospho-IDH). Although the significance of this observation remains to be determined, it suggests the presence of a feedback control mechanism for the expression of this protein. If such a mechanism exists, the extensive inhibition of IDH that resulted from expression of aceK3 or aceK4 would be expected to yield an increase in the level of icd expression.
Determination of the lower limit of IDH activity required for growth on acetate. The results of previous studies (discussed below) have suggested, albeit indirectly, that the fractional phosphorylation of IDH must be precisely controlled in cells growing on acetate (20, 21) . The availability of aceK3 and aceK4 allowed us to directly test the extent to which the fractional phosphorylation of IDH could be perturbed without preventing growth on acetate. Since the products of aceK3 and aceK4 lack significant IDH phosphatase activity, expression of these genes in an aceK+ strain allowed us to unbalance the IDH phosphorylation cycle and thereby vary the fractional phosphorylation of this protein. aceK3 was selected for these experiments, since expression of this gene prevented growth of the aceK+ host on acetate (Table 3) . In order to control the expression of aceK3, we constructed plasmid pDL26, which expressed this gene along with lacIq, the gene encoding the lac repressor. Since aceK3 is expressed from the tac promoter, expression of this gene from pDL26 can be controlled with the gratuitous inducer IPTG.
Strain DL18 (aceK+) harboring plasmid pDL26 (aceK3) exhibited a wild-type growth rate on acetate medium even though the basal expression of aceK3 reduced the effective IDH activity by a factor of 2 relative to a congenic wild-type strain (Fig. 2) . However, addition of IPTG (Fig. 2, (3, 4, 7, 8) . In addition, it has recently been reported that the protein kinases that participate in at least some of the two component regulatory systems of E. coli (26, 27) may also possess protein phosphatase activities. This was first reported for NTRB, a protein involved in control of transcription in the nitrogen regulon (13) , and was subsequently found for a similar protein, EnvZ (12) . It is intriguing that, like IDH phosphatase, the phosphatase activities of NTRB and EnvZ are dependent on ATP. Our working model for IDH kinase/phosphatase proposes that the kinase and phosphatase reactions occur in the same active site and that the IDH phosphatase reaction results from the back reaction of IDH kinase coupled with ATP hydrolysis (19) . The ATP requirement exhibited by the NTRB and EnvZ phosphatase activity suggests that these reactions may occur by a similar mechanism. During growth on acetate, the wild-type IDH phosphorylation system exhibits a striking ability to maintain IDH activity within a very narrow range. For example, in a previous study we found that the IDH phosphorylation cycle could precisely compensate for a 30-fold variation in the level of IDH, converting excess IDH into its inactive, phosphorylated form (20) . Although the extent to which the IDH phosphorylation cycle could compensate for changes in the level of expression of IDH was striking, the need to maintain IDH activity within a fairly narrow range during growth on acetate was expected. This need results because the branch point between the glyoxylate bypass and the Krebs cycle was predicted to exhibit an amplified sensitivity to the activity of IDH, a phenomenon which results from the large difference between the Michaelis constants of IDH and isocitrate lyase for isocitrate (8 and 600 ,uM, respectively) (21) . Consistent with this expectation, null mutations in aceK, which should yield only a three-to fourfold increase in IDH activity, prevent growth on acetate (20) . However, the cell's ability to tolerate a decrease in IDH activity during growth on acetate remained to be determined. To examine this issue, we varied the fractional phosphorylation of IDH by controlled expression of aceK3 in an aceK+ background. Growth on acetate was apparently unaffected by a 50% decrease in IDH activity relative to that of the wild type. However, further reductions in IDH activity led to severe growth inhibition. It appears, therefore, that the system has only a limited tolerance for variations in IDH activity during growth on acetate.
Why does excessive inhibition of IDH prevent growth on acetate? The answer to this question probably lies in the different functions served by the glyoxylate bypass and the Krebs cycle. The principal function of the glyoxylate bypass is to replenish the metabolic intermediates which are consumed by biosynthetic processes, whereas the Krebs cycle is primarily responsible for the production of metabolic energy and NADPH. Failure to correctly balance these essential processes would be likely to inhibit growth, as discussed below.
Excessive inhibition of IDH may have caused the flux of the glyoxylate bypass to exceed the cell's biosynthetic needs, a condition which could result in the accumulation of potentially toxic metabolites such as glyoxylate or oxaloacetate. These metabolites are not toxic in wild-type cells because they are maintained at low concentrations and because a large fraction of their cellular pools is bound to the active sites of the enzymes responsible for their metabolism (28) . The potential accumulation of toxic metabolites may be a factor in determining the lower limit of IDH activity which is required for growth on acetate. Depletion of the cellular energy level might also have contributed to growth arrest. The glyoxylate cycle does produce some metabolic energy, since it shares several steps with the Krebs cycle. However, production of energy in the Krebs cycle is far more efficient; this pathway yields the equivalent of 9 molecules of ATP per acetyl coenzyme A consumed, whereas the glyoxylate cycle yields only 3.5. How much energy is required for growth on acetate? Surprisingly, only 35% of the metabolic energy which is generated under these conditions appears to be required for biosynthetic and transport functions (29) . The fate of the bulk of this energy production is unclear, but it may be consumed by the "housekeeping" functions which are required even in the absence of growth (e.g., maintenance of the membrane potential). The (29) . The IDH activity which remained at the time of growth arrest was probably sufficient for glutamate production.
The accumulation of toxic metabolites and the depletions of cellular energy and NADPH resulting from the excessive inhibition of IDH are each likely to have been detrimental to cell growth. However, the relative contributions of each mechanism remain to be determined. To address this question, we will need to measure the fluxes of both the glyoxylate bypass and the Krebs cycle and the cellular levels of key metabolites.
To date, the only substrate which has been identified for IDH kinase/phosphatase is IDH. The possibility that IDH is the sole substrate for this bifunctional regulatory protein is supported by genetic as well as biochemical evidence.
Strains with null alleles of aceK can be restored to growth on acetate by second-site mutations in icd, the gene encoding IDH (20 
